Hunter Gillies, CHIEF MEDICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 13,387 shares at $25.81 ($346K) on 2024-03-18, disclosed to the SEC on 2024-03-20.
Scheduled sale ($346k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.81 | 6,387 | $165K | 47.7% |
| 2 | $25.81 | 6,387 | $165K | 47.7% |
| 3 | $26.40 | 613 | $16K | 4.7% |
| Total | $25.84 avg | 13,387 | $346K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-19 | $172K | — | Filing → |
| AVTE | SELL | 2024-04-01 | $266K | — | Filing → |
| AVTE | SELL | 2024-03-11 | $440K | — | Filing → |